Guardant Health acquires MetaSight amid positive 2026 financial outlook
Cancer diagnostics specialist Guardant Health has completed its $149m acquisition of health technology company, MetaSight Diagnostics, as the company gears…
Cancer diagnostics specialist Guardant Health has completed its $149m acquisition of health technology company, MetaSight Diagnostics, as the company gears…
Pulse Biosciences has entered a research partnership with The University of Texas MD Anderson Cancer Center, US, to investigate the…
Lunit has announced the submission of a 510(k) premarket notification seeking clearance from the US Food and Drug Administration (FDA)…
Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the US. Exceeding $200m,…
Myriad Genetics has broadened the scope of its MyRisk Hereditary Cancer Test for germline testing, adding genes cited in the…
Princess Margaret Cancer Centre, part of Canada's University Health Network (UHN), has partnered with genomics company Helix to undertake the…
Breast cancer is the most diagnosed cancer in women worldwide. During October, breast cancer awareness month, community outreach should be…
Color Health, in collaboration with Google Cloud, has unveiled an initiative aimed at increasing the accessibility of breast cancer screening.…
Samsung C&T (SCT) and Samsung Electronics (SEC) have joined forces with Grail, a healthcare company, to advance the availability of…
A research team spearheaded by Harvard Medical School (HMS) in the US has created an AI tool, dubbed Pathology Image…